Digestive and Liver Disease最新文献

筛选
英文 中文
Clinical characteristics and prognostic factors of ascitic fungal infections in patients with cirrhosis. 肝硬化腹水真菌感染的临床特点及预后因素分析。
IF 4.9 3区 医学
Digestive and Liver Disease Pub Date : 2026-11-14 DOI: 10.1016/j.dld.2026.10.024
Xiaoxi Li, Xin Zhang, Fuyu Lu, Yuhao Yi, Suming Chen, Fusheng Wang, Chunmei Bao, Lei Huang
{"title":"Clinical characteristics and prognostic factors of ascitic fungal infections in patients with cirrhosis.","authors":"Xiaoxi Li, Xin Zhang, Fuyu Lu, Yuhao Yi, Suming Chen, Fusheng Wang, Chunmei Bao, Lei Huang","doi":"10.1016/j.dld.2026.10.024","DOIUrl":"https://doi.org/10.1016/j.dld.2026.10.024","url":null,"abstract":"<p><strong>Background and aims: </strong>To investigate the clinical characteristics, pathogen spectrum, antifungal susceptibility, and prognostic factors of ascitic fungal infections in patients with cirrhosis.</p><p><strong>Methods: </strong>This retrospective study included cirrhotic patients with positive ascitic fungal cultures. Patients with ascitic bacterial infections served as controls. Clinical, laboratory, and microbiological data were analyzed.</p><p><strong>Results: </strong>A total of 108 patients were included, comprising 57 with spontaneous fungal peritonitis (SFP) and 51 with fungiascites (FA). Among 116 fungal isolates recovered from ascitic fluid, 107 were Candida spp. Most isolates were susceptible to antifungal agents, although notable azole resistance was observed among non-albicans Candida species. Patients with SFP had higher mortality than those with FA (29.8% vs 13.7%, p = 0.045) and spontaneous bacterial peritonitis (29.8% vs 7.0%, p = 0.002). A nomogram incorporating serum urea (>18 mmol/L), neutrophil count (>10 × 10<sup>9</sup>/L), and platelet count (<75 × 10<sup>9</sup>/L) may facilitate early assessment of 30-day mortality.</p><p><strong>Conclusions: </strong>Ascitic fluid fungal infections, particularly SFP, are associated with significantly worse outcomes than bacterial ascitic infections. The primary pathogens are Candida spp., with high susceptibility to azole antifungals.</p>","PeriodicalId":11268,"journal":{"name":"Digestive and Liver Disease","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149403309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Children are not small adults: adult-derived evidence and reporting inconsistencies in pediatric endoscopy. 儿童不是小大人:儿童内窥镜检查中来自成人的证据和报告的不一致。
IF 4.9 3区 医学
Digestive and Liver Disease Pub Date : 2026-11-12 DOI: 10.1016/j.dld.2026.10.020
Jia Chen, Xu Zhang, Lei Zhu
{"title":"Children are not small adults: adult-derived evidence and reporting inconsistencies in pediatric endoscopy.","authors":"Jia Chen, Xu Zhang, Lei Zhu","doi":"10.1016/j.dld.2026.10.020","DOIUrl":"https://doi.org/10.1016/j.dld.2026.10.020","url":null,"abstract":"","PeriodicalId":11268,"journal":{"name":"Digestive and Liver Disease","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149403308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author's Reply: ``Follow-up eligibility and predictive value estimation in hepatocellular carcinoma risk stratification''. 作者回复:“肝细胞癌风险分层的随访资格及预测价值评估”。
IF 4.9 3区 医学
Digestive and Liver Disease Pub Date : 2026-11-12 DOI: 10.1016/j.dld.2026.10.034
Mohamed Moussa, Dave Sprengers, M J Sonneveld
{"title":"Author's Reply: ``Follow-up eligibility and predictive value estimation in hepatocellular carcinoma risk stratification''.","authors":"Mohamed Moussa, Dave Sprengers, M J Sonneveld","doi":"10.1016/j.dld.2026.10.034","DOIUrl":"https://doi.org/10.1016/j.dld.2026.10.034","url":null,"abstract":"","PeriodicalId":11268,"journal":{"name":"Digestive and Liver Disease","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149403307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond physician perspectives: advancing simultaneous care in pancreatic adenocarcinoma through multidisciplinary and implementation science approaches. 超越医生的观点:通过多学科和实施科学方法推进胰腺腺癌的同步护理。
IF 4.9 3区 医学
Digestive and Liver Disease Pub Date : 2026-11-11 DOI: 10.1016/j.dld.2026.10.029
Jing Su, Juan Yang, Qiuqiong Li, Na Li
{"title":"Beyond physician perspectives: advancing simultaneous care in pancreatic adenocarcinoma through multidisciplinary and implementation science approaches.","authors":"Jing Su, Juan Yang, Qiuqiong Li, Na Li","doi":"10.1016/j.dld.2026.10.029","DOIUrl":"https://doi.org/10.1016/j.dld.2026.10.029","url":null,"abstract":"","PeriodicalId":11268,"journal":{"name":"Digestive and Liver Disease","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149393262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
When mucosa is quiet but symptoms persist: why EoE deserves more than an empiric dilatation. 当粘膜平静但症状持续时:为什么EoE应不仅仅是经验性扩张。
IF 4.9 3区 医学
Digestive and Liver Disease Pub Date : 2026-11-10 DOI: 10.1016/j.dld.2026.09.006
Jianlei Zhang, Wenbin Dai, Pan Zhou
{"title":"When mucosa is quiet but symptoms persist: why EoE deserves more than an empiric dilatation.","authors":"Jianlei Zhang, Wenbin Dai, Pan Zhou","doi":"10.1016/j.dld.2026.09.006","DOIUrl":"https://doi.org/10.1016/j.dld.2026.09.006","url":null,"abstract":"","PeriodicalId":11268,"journal":{"name":"Digestive and Liver Disease","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149385764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fibrotic complications in ulcerative colitis are associated with early and persistent healthcare burden. 溃疡性结肠炎的纤维化并发症与早期和持续的医疗负担有关。
IF 4.9 3区 医学
Digestive and Liver Disease Pub Date : 2026-11-07 DOI: 10.1016/j.dld.2026.10.031
Ilona Shapiro, Ebuwa Igho-Osagie, Sarah Sharman Moser, Garrett Lawlor, Moshe Hoshen, Gui Liu, Sivan Gazit, Florian Rieder, Amir Ben-Tov
{"title":"Fibrotic complications in ulcerative colitis are associated with early and persistent healthcare burden.","authors":"Ilona Shapiro, Ebuwa Igho-Osagie, Sarah Sharman Moser, Garrett Lawlor, Moshe Hoshen, Gui Liu, Sivan Gazit, Florian Rieder, Amir Ben-Tov","doi":"10.1016/j.dld.2026.10.031","DOIUrl":"https://doi.org/10.1016/j.dld.2026.10.031","url":null,"abstract":"<p><strong>Background and aims: </strong>Ulcerative colitis (UC) is traditionally considered a mucosal, non-fibrostenosing inflammatory bowel disease, yet emerging evidence suggests that fibrosis is more clinically relevant in UC than previously recognized. Population-based data describing the risk factors and healthcare burden of fibrotic complications in UC are limited.</p><p><strong>Methods: </strong>We conducted a retrospective population-based cohort study using data from Maccabi Healthcare Services, a nationwide insurer-provider. Non-malignant strictures, stenosis, or obstruction post-UC diagnosis were used as a proxy for fibrotic complications. Risk factors were assessed using Cox regression. Patients with fibrotic complications were then matched to controls to compare healthcare resource utilization (HCRU) and treatment patterns.</p><p><strong>Results: </strong>Among 6,944 patients with UC, 100 (1.4%) developed fibrotic complications. Older age at diagnosis (HR [95%CI]=1.81[1.05-3.13] for ages 41-65 and 2.75[1.30-5.80] for >65 vs. 18-40), comorbidities (1.73[1.04-2.88]), and advanced therapy exposure (4.38[2.47-7.74]) were independently associated with increased risk of fibrotic complications, whereas proctitis at presentation was protective (0.49[0.31-0.78]). Patients with fibrotic complications had higher HCRU, medication use, and costs throughout the disease course, evident even before fibrotic complication diagnosis, with a further increase in HCRU post-diagnosis.</p><p><strong>Conclusions: </strong>Fibrotic complications in UC are associated with substantial clinical and healthcare burden, underscoring the need for improved risk stratification, earlier recognition, and further investigation of targeted antifibrotic strategies.</p>","PeriodicalId":11268,"journal":{"name":"Digestive and Liver Disease","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149370144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interpreting early bile acid reduction for pruritus reassessment in PFIC. 早期胆汁酸减少对PFIC患者瘙痒重评的意义。
IF 4.9 3区 医学
Digestive and Liver Disease Pub Date : 2026-11-07 DOI: 10.1016/j.dld.2026.10.033
Xin Chang
{"title":"Interpreting early bile acid reduction for pruritus reassessment in PFIC.","authors":"Xin Chang","doi":"10.1016/j.dld.2026.10.033","DOIUrl":"https://doi.org/10.1016/j.dld.2026.10.033","url":null,"abstract":"","PeriodicalId":11268,"journal":{"name":"Digestive and Liver Disease","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149370145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neoadjuvant immunochemotherapy vs. neoadjuvant chemotherapy or concurrent chemoradiotherapy in unresectable locally advanced esophageal squamous cell carcinoma. 新辅助免疫化疗与新辅助化疗或同步放化疗在不可切除的局部晚期食管鳞状细胞癌中的比较。
IF 4.9 3区 医学
Digestive and Liver Disease Pub Date : 2026-11-04 DOI: 10.1016/j.dld.2026.10.032
Run-Zhi Wang, Cheng-Xian Ma, Huan-Wei Liang, Wei Huang, Xin-Bin Pan
{"title":"Neoadjuvant immunochemotherapy vs. neoadjuvant chemotherapy or concurrent chemoradiotherapy in unresectable locally advanced esophageal squamous cell carcinoma.","authors":"Run-Zhi Wang, Cheng-Xian Ma, Huan-Wei Liang, Wei Huang, Xin-Bin Pan","doi":"10.1016/j.dld.2026.10.032","DOIUrl":"https://doi.org/10.1016/j.dld.2026.10.032","url":null,"abstract":"<p><strong>Purpose: </strong>To compare the efficacy between neoadjuvant immunochemotherapy (NICT), neoadjuvant chemotherapy (NCT), and concurrent chemoradiotherapy (CCRT) in patients with unresectable locally advanced esophageal squamous cell carcinoma.</p><p><strong>Materials and methods: </strong>We retrospectively analyzed patients with stage II-IVA disease treated between January 2013 and May 2024. Patients were categorized into the CCRT, NCT, and NICT groups. Survival outcomes were compared using Kaplan-Meier analysis and Cox proportional hazards models.</p><p><strong>Results: </strong>A total of 347 patients were included: 214 (61.7%) in the CCRT group, 42 (12.1%) in the NCT group, and 91 (26.2%) in the NICT group. Compared with CCRT, NICT was associated with improved disease-free survival (HR = 0.57, 95% CI: 0.41-0.80, P = 0.001) and overall survival (HR = 0.48, 95% CI: 0.32-0.72, P < 0.001). Compared with NCT, NICT was associated with improved disease-free survival (HR = 0.51, 95% CI: 0.32-0.79, P = 0.003) and overall survival (HR = 0.40, 95% CI: 0.24-0.65, P < 0.001). The survival benefit associated with NICT was observed in patients who received >3 cycles (HR = 0.31, 95% CI: 0.15-0.63, P = 0.001).</p><p><strong>Conclusion: </strong>NICT was associated with improved survival compared with either NCT or CCRT. These findings are hypothesis-generating and require prospective validation.</p>","PeriodicalId":11268,"journal":{"name":"Digestive and Liver Disease","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149332897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Postoperative vedolizumab in Crohn's disease: interpreting persistence, endoscopic recurrence, and treatment strategy. 克罗恩病术后维多单抗:解释持续性、内镜下复发和治疗策略
IF 4.9 3区 医学
Digestive and Liver Disease Pub Date : 2026-11-03 DOI: 10.1016/j.dld.2026.10.030
Leyi Xu, Ting Ye
{"title":"Postoperative vedolizumab in Crohn's disease: interpreting persistence, endoscopic recurrence, and treatment strategy.","authors":"Leyi Xu, Ting Ye","doi":"10.1016/j.dld.2026.10.030","DOIUrl":"https://doi.org/10.1016/j.dld.2026.10.030","url":null,"abstract":"","PeriodicalId":11268,"journal":{"name":"Digestive and Liver Disease","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149319037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Awareness and clinical management of metabolic dysfunction-associated steatotic liver disease among physicians in Milan: a cross-sectional survey. 米兰医生对代谢功能障碍相关脂肪变性肝病的认识和临床管理:一项横断面调查
IF 4.9 3区 医学
Digestive and Liver Disease Pub Date : 2026-11-02 DOI: 10.1016/j.dld.2026.10.023
Jessica Rondena, Roberta Gualtierotti, Roberto Carlo Rossi, Luca Valenti
{"title":"Awareness and clinical management of metabolic dysfunction-associated steatotic liver disease among physicians in Milan: a cross-sectional survey.","authors":"Jessica Rondena, Roberta Gualtierotti, Roberto Carlo Rossi, Luca Valenti","doi":"10.1016/j.dld.2026.10.023","DOIUrl":"https://doi.org/10.1016/j.dld.2026.10.023","url":null,"abstract":"","PeriodicalId":11268,"journal":{"name":"Digestive and Liver Disease","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149319034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书